Home » Topics » Regulatory » NMPA

NMPA
RSS

Toripalimab first domestically produced anti-PD-1 MAb approved in China

Dec. 20, 2018

China becomes first country to approve roxadustat

Dec. 18, 2018

China SFDA clears phase I trial of A-319 in B-cell malignancies

Nov. 13, 2018

Elunate approved in China for colorectal cancer

Sep. 5, 2018

CFDA approves INDs for Innovent's IBI-101 and IBI-307

July 27, 2018

Luye cleared for phase I trials in China with LY-03012

June 21, 2018

CFDA grants priority review to Pharnext's PXT-3003 for CMT1A

June 14, 2018

Ganovo approved in China for hepatitis C

June 13, 2018

CFDA clears HG-146 to enter clinical trials for multiple myeloma

May 11, 2018

CFDA approves IND for Suzhou Alphamab's HER2 bispecific antibody KN-026

April 16, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 10, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026